Physician profile
James D Oholleran
NPI 1700864303
$82,255.48
in general payments reported to CMS, 2019-2025
19 companies · $194 in 2025
The $194 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $11K · 2021: $12K · 2022: $5,729 · 2023: $17K · 2024: $23K · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $37K · Travel and Lodging: $2,664 · Food and Beverage: $1,017.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $36,550.70 |
| Travel and Lodging | $2,663.83 |
| Food and Beverage | $1,017.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $57,116.29 | 2019-2024 | Rigidloop, Fms Duo, Monovisc |
| Depuy Synthes Products, INC. | $22,120.76 | 2020-2024 | Rigidloop, Fms Duo, Monovisc |
| Smith+Nephew, INC. | $1,842.03 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Bone Anchors With Arthroscopic Delivery System, Pico |
| Depuy Synthes Sales INC. | $452.44 | 2019-2025 | Fms Duo, Rigidloop, Dynacord |
| Pacira Therapeutics, INC. | $171.22 | 2019-2021 | |
| Bioventus LLC | $118.17 | 2021-2024 | Exogen Ultrasound Bone Healing System, Supartz Fx Sodium Hyaluronate, Exogen Ultrasound Bone Healing System |
| Ferring Pharmaceuticals INC. | $117.91 | 2019-2022 | |
| Abbott Laboratories | $48.32 | 2022-2023 | Proclaim |
| Pacira Pharmaceuticals Incorporated | $47.27 | 2022-2024 | Exparel, Iovera, Zilretta |
| Stryker Corporation | $42.14 | 2021-2023 | Pro-Dense, Allomatrix, Prophecy |
| Regeneron Healthcare Solutions, INC. | $32.80 | 2025 | Dupixent |
| Avanos Medical | $20.78 | 2021 | |
| Janssen Pharmaceuticals, INC | $20.39 | 2020 | |
| Orthofix Medical, INC. | $20.03 | 2025 | Physio-Stim |
| Vertex Pharmaceuticals Incorporated | $19.90 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $18.42 | 2022 | |
| Acumed LLC | $17.08 | 2024 | Inframe Implant |
| Acelrx Pharmaceuticals, INC. | $15.27 | 2019 | |
| Zimvie INC. | $14.26 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Oholleran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.